With the first bellwether Actos (pioglitazone) cancer trial approaching, the outcome of thousands of pending lawsuits is at stake. More than 3,000 lawsuits are currently pending in federal court against makers of the Type 2 diabetes medicine Actos for alleged injuries, including the development of bladder cancer.

The first bellwether trial is scheduled to begin Jan. 27. Bellwether trials are important, because they are used to represent plaintiffs alleging similar injuries and will set the tone for the outcome of those cases.

The first bellwether trial involves a plaintiff who was diagnosed with bladder cancer in 2011 after taking Actos from 2004 to 2011. The plaintiff and his spouse are arguing that he developed bladder cancer after taking Actos and that the drug maker failed to warn about the potential risk of bladder cancer associated with the diabetes medication.

In 2011, the U.S. Food and Drug Administration (FDA) issued an Actos warning stating that results from an ongoing study showed that patients who took high doses of Actos for more than one year had a 40 percent higher risk of bladder cancer. Despite the findings, the FDA has chosen to keep the medication on the market. Based on similar findings, pioglitazone has been barred from use in France and Germany.

Instead of pulling Actos from the U.S. market, the FDA issued warnings and required that Takeda add a bladder cancer warning to Actos’ drug label. Before the warning was issued in 2011, thousands of people had already taken the medication without warning.

If you are among the thousands of people that have been prescribed Actos and you have been diagnosed with bladder cancer, you may eligible for financial compensation. To learn more, contact the defective drug lawyers at Berkowitz and Hanna LLC in Connecticut. Our lawyers will be watching the upcoming bellwether Actos trials to see what is in store for other plaintiffs making similar allegations.

To find out if you qualify to file an Actos cancer lawsuit, on behalf of yourself or a loved one who has died, call our office today. We would be happy to assess your case free of charge and to let you know if and how we can help you.